Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Summary

This study will evaluate the effects of immediate release (IR) carbidopa levodopa versus the effects of immediate-release carbidopa/levodopa on ERP parameters in patients with idiopathic PD.

Timeline

Start

2008-08

Primary completion

2009-11

Completion

2009-11

Outcome

Outcome not reported

Stopped (Enrollment): “Business decision brand strategy; no patients enrolled”

Drugs

Indications